Trial of Lixisenatide in Early Parkinson’s DiseaseWassilios G. Meissner, Olivier Rascol, Olivier Colin et al.|New England Journal of Medicine|2024Cited by 302
Small P values may not yield robust findings: an example using REST-meta-PDXi-Ze Jia, Alessia Sarica, Na Zhao et al.|Science Bulletin|2021Cited by 33
Small effect size leads to reproducibility failure in resting-state fMRI studiesXize Jia, James M. Shine, Na Zhao et al.|bioRxiv (Cold Spring Harbor Laboratory)|2018Cited by 13
AZP2006 in Progressive Supranuclear Palsy: A Multi-Centre, Randomized, Phase 2a Trial Assessing Safety and Biomarker OutcomesJean‐Christophe Corvol, Luc Defebvre, Mickaël Alexandre Obadia et al.|SSRN Electronic Journal|2024Cited by 0
AZP2006 in Progressive Supranuclear Palsy: A Multi-Centre, Randomized, Phase 2a Trial Assessing Safety and Biomarker OutcomesJean‐Christophe Corvol, Luc Defebvre, Mickaël Alexandre Obadia et al.|SSRN Electronic Journal|2024Cited by 0